Swiss-based pharma selects InnaPhase's EP Series to manage PK/PD information

According to InnaPhase, its EP Series is an enterprise technology solution for data management and analysis, designed to consolidate early drug development data and comply with FDA guidelines on elect

By Editor on Jul 1, 2002

According to InnaPhase, its EP Series is an enterprise technology solution for data management and analysis, designed to consolidate early drug development data and comply with FDA guidelines on electronic records and signatures (21 CFR Part 11). The EP Series is a protocol-driven system for managing early development data, and provides data analysis and reporting capabilities designed to expedite early drug development processes.